BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Joseph Schwartz does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 FULCFulcrum Therapeutics Inc | Buy | $12.00 | May 2025 | −7.9% | Hit |
 MAZEMaze Therapeutics, Inc. Common Stock | Buy | $28.00 | Feb 2025 | +295.0% | Hit |
 ANTXAN2 Therapeutics Inc | Buy | — | Jul 2024 | −55.5% | — |
 MREOMereo BioPharma Group PLC ADR | Buy | $8.00 | Jun 2024 | −20.2% | Miss |
 PHVSPharvaris BV | Buy | $18.00 | Feb 2023 | +236.2% | Hit |
| ANTXAN2 Therapeutics Inc | Buy | $25.00 | Nov 2022 | +10.7% | Miss |
 AUPHAurinia Pharmaceuticals Inc | Buy | $12.00 | Nov 2022 | +65.6% | Hit |
| PHVSPharvaris BV | Buy | $20.00 | Sep 2022 | +116.1% | Hit |
| PHVSPharvaris BV | Buy | $25.00 | Aug 2022 | +93.6% | Hit |
 SLDBSolid Biosciences LLC | Buy | $15.00 | Apr 2022 | −46.1% | Miss |
| PHVSPharvaris BV | Buy | $45.00 | Mar 2022 | −54.6% | Miss |
 SYBXSynlogic Inc | Buy | $8.00 | Mar 2022 | −64.1% | Miss |
| AUPHAurinia Pharmaceuticals Inc | Buy | $22.00 | Mar 2022 | −11.5% | Miss |
| SYBXSynlogic Inc | Buy | $11.00 | Nov 2021 | −74.2% | Miss |
| SLDBSolid Biosciences LLC | Buy | $15.00 | Mar 2021 | −100.3% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.